Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT06704672 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus

Interventions

DEVICE: Accu-Chek SmartGuide CGM Solution
DEVICE: Accu-Chek SmartGuide Sensor and Blinded Apps
DEVICE: SMBG Device

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]